Clinical Trial Update: Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer [Phase 1]

View source ↗

Summary

Phase 1 trial results examining hydroxychloroquine as a potential insulin sensitizer in insulin resistance, with initial safety and pharmacodynamic findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University of Pittsburgh | Conditions: Insulin Resistance | Phase 1 | Status: COMPLETED